「for」の検索結果
119件：21～25件目を表示
-
千寿製薬株式会社
se through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
http://www.senju.co.jp/chinese/ -
ealth and prosperity by the realization and synergy of Senju’s mission of the “Pursuit of happiness for all people”, and Rexxam’s` policy the “Take boldly on any challenge, while putting ourselves in ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
https://www.senju.co.jp/rd/policy/ -
Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into a LicensingAgreement for Corneal Esthesiometer Brill in Japan with Brill International (Headquarters: Barcelona, Spain; C...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
al of Ophthalmology. 2026;283:163-175. 外部リンク Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
https://www.senju.co.jp/rd/thesis/